Gastroenterology Search
Gastroenterology Gastroenterology
irritable%20bowel%20syndrome
IRRITABLE BOWEL SYNDROME
Irritable bowel syndrome is a common chronic gastrointestinal condition characterized by abdominal pain and bloating with altered bowel habits.
There are no identifiable physical, radiologic or lab abnormalities indicative of organic disease.
Symptoms may be exacerbated by stress, alcohol or food.

Irritable Bowel Syndrome Drug Information

Drug Information
Bioflor
Saccharomyces boulardii

Indication: Acute infectious diarrhoea in infants, childn & adults. Prevention of antibiotic-associated diarrhoea in c...

Indication: Chronic constipation; pre-coma & coma hepaticum.

Agiolax
plantago ovata husks + plantago seeds + sennosides

Indication: Traditionally used for constipation.

Indication: Symptomatic treatment & relief associated w/ irritable bowel syndrome (abdominal pain, bowel disturbances ...

Indication: Symptomatic treatment of abdominal pain & cramps, bowel disturbances & intestinal discomfort related t...

Indication: Symptomatic control of acute & chronic diarrhea; reduce number & vol of stools & harden their cons...

Indication: Relief of constipation & helps in stool softening. Hepatic encephalopathy.

Indication: GIT & GUT spasm, biliary system spasm & dyskinesia.

Indication: Acute spasm, as in renal or biliary chronic, in radiology for differential diagnosis of obstruction. Reduction...

Forlax
macrogol 4000

Indication: Symptomatic treatment of constipation in adults & childn ≥8 yr.

1  /  5
1  /  5
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Gastroenterology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Carfilzomib-based triplet regimen a potential upfront treatment for high-risk MM
Pearl Toh, 3 days ago
The combination therapy comprising carfilzomib, cyclophosphamide and dexamethasone (KCd) is effective, with a tolerable safety profile, in an Asian cohort with high-risk multiple myeloma (MM) — thus providing a more economical alternative as a potential upfront regimen in resource-limited settings, according to leading experts during a myeloma education webinar.
Extreme sleep duration may up mortality risk in individuals with T2D
Audrey Abella, 5 days ago
Extremes of sleep duration (≤5 or ≥10 hours/day), which is a known mortality risk factor in the general population, may increase absolute mortality in adults with type 2 diabetes (T2D), a prospective study has shown.
How to control asthma well: Experts’ perspectives
Pearl Toh, 21 Sep 2020
Early and sustained treatments with simplified regimen are the key to achieving good asthma control, said experts during a presentation at the ERS 2020 Congress.
Once-weekly insulin as good as once-daily dose?
Roshini Claire Anthony, 12 Oct 2020

Insulin icodec, an in-development basal insulin analogue administered once weekly, was as effective as once-daily insulin glargine in patients with type 2 diabetes (T2D) insufficiently controlled with metformin with or without a DPP-4* inhibitor, according to a phase II trial presented at EASD 2020.